Page last updated: 2024-11-03

proglumetacin and Joint Diseases

proglumetacin has been researched along with Joint Diseases in 9 studies

proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.

Joint Diseases: Diseases involving the JOINTS.

Research Excerpts

ExcerptRelevanceReference
"Thirty patients with articular pain had been treated with proglumetacin during average 12 days."7.66[Proglumetacin for fast and safe control of joint pain of orthopedic importance]. ( Bertini, G; Lorenzi, GL; Peveraro, A, 1983)
"6 +/- 12,9 years) with orthopedic-traumatologic disorders (osteoarthritis, 38; painful joints, 26; fibrositis, painful shoulder, 20; peri- and extra-articular disorders, 13) had been treated during 7 to 30 days with two suppositories (400 mg) or three capsules (450 mg) proglumetacin (Proxil Rorer)."5.05[Proglumetacin: possible first choice in the treatment of orthopedic- traumatologic disorders]. ( Gusso, MI; Guzzo, GC; Pennisi, M, 1985)
"Twenty-nine patients with gouty arthritis, rheumatoid arthritis and osteoarthritis were treated as outpatients with proglumetacin, at different doses, during 5-30 days."3.66[Proglumetacin for a wide spectrum of activity in clinical medicine]. ( Fossaluzza, V, 1983)
"Thirty patients with articular pain had been treated with proglumetacin during average 12 days."3.66[Proglumetacin for fast and safe control of joint pain of orthopedic importance]. ( Bertini, G; Lorenzi, GL; Peveraro, A, 1983)
"Proglumetacin was administered as a sole treatment during 15 days at 450 mg/day to 20 patients with osteoarthritis localized in several joints."1.27[Short-term effects of proglumetacin in arthrosis]. ( Fioravanti, A; Giordano, N; Marcolongo, R, 1983)
"Proglumetacin was well-tolerated by all patients."1.26Proglumetacin (protacine): a promising new treatment of the rheumatic joint. ( Rivera, IC, 1982)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zanoli, S1
Pace, N1
Raffaelli, P1
Tonon, R1
Simioni, M1
Lazzarin, P1
Bedendo, A1
Todesco, S1
Marcolongo, R1
Giordano, N1
Fioravanti, A1
Fossaluzza, V1
Larosa, F1
Vittore, D1
Mazzarisi, A1
Molfetta, L1
Ardito, S1
Leonardi, W1
Longo, G1
Lorenzi, GL1
Bertini, G1
Peveraro, A1
Rivera, IC1
Gusso, MI1
Guzzo, GC1
Pennisi, M1

Trials

1 trial available for proglumetacin and Joint Diseases

ArticleYear
[Proglumetacin: possible first choice in the treatment of orthopedic- traumatologic disorders].
    Minerva medica, 1985, Mar-24, Volume: 76, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Fi

1985

Other Studies

8 other studies available for proglumetacin and Joint Diseases

ArticleYear
[Short-term study of proglumetacin].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adult; Aged; Back Pain; Brachial Plexus Neuritis; Drug Evaluation; Drug Tolerance; Female; Humans; I

1983
[Proglumetacin for the treatment of inflammatory and degenerative arthropathies].
    Minerva medica, 1984, May-12, Volume: 75, Issue:20

    Topics: Adult; Aged; Arthritis, Rheumatoid; Drug Tolerance; Female; Humans; Indoleacetic Acids; Joint Diseas

1984
[Short-term effects of proglumetacin in arthrosis].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Drug Evaluation; Drug Tolerance; Humans; Indoleacetic Acids; Joint Diseases; Muscle Rigidity; Pain

1983
[Proglumetacin for a wide spectrum of activity in clinical medicine].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adult; Aged; Arthritis, Rheumatoid; Diabetes Complications; Drug Tolerance; Female; Gout; Humans; In

1983
[Joint pain crises and chronic inflammatory-reactive phenomena: a unitary approach with proglumetacin].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Acute Disease; Adult; Aged; Arthritis, Rheumatoid; Drug Evaluation; Drug Tolerance; Female; Humans;

1983
[Proglumetacin: a simple and practical anti-inflammatory agent for the treatment of hospitalized orthopedic patients].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adolescent; Adult; Aged; Arthritis; Bursitis; Child; Drug Evaluation; Drug Tolerance; Female; Humans

1983
[Proglumetacin for fast and safe control of joint pain of orthopedic importance].
    Minerva medica, 1983, Jun-23, Volume: 74, Issue:26

    Topics: Adult; Aged; Arm; Drug Evaluation; Drug Tolerance; Female; Hand; Humans; Indoleacetic Acids; Joint D

1983
Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
    Pharmatherapeutica, 1982, Volume: 3, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Humans; Indoleacetic Acids; Jo

1982